SCHEMBL12413534

SCHEMBL12413534

C=C1c2ccccc2NC(=O)N1C(C)C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.53
MAPT P10636 4/20 0.49
KDM4E B2RXH2 5/20 0.41
RECQL P46063 1/20 0.41
HSD17B10 Q99714 2/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
PDGFRA P16234 1/20 0.40
FER P16591 1/20 0.40
LTK P29376 1/20 0.40
CDK8 P49336 1/20 0.40
ACVR1 Q04771 1/20 0.40
LRRK2 Q5S007 1/20 0.40
DYRK1B Q9Y463 1/20 0.40
EGFR P00533 1/20 0.37
ERBB2 P04626 1/20 0.37
IGF1R P08069 1/20 0.37
PDGFRB P09619 1/20 0.37
GLB1 P16278 1/20 0.37
CTRC Q99895 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12413535 0.78 GSK3B (0.36) ALDH1A1MAPTKDM4EMAOAMAOB
SCHEMBL3112406 0.77 ALDH1A1 (0.57) ALDH1A1MAPTKDM4EHSD17B10MAOA
SCHEMBL12260197 0.74 TDP1 (0.49) ALDH1A1MAPTMAOBGAAPOLB
SCHEMBL12700074 0.72 ALDH1A1 (0.53) ALDH1A1MAPTKDM4EHSD17B10MAOA
SCHEMBL15131073 0.71 SMN1; SMN2 (0.39) ALDH1A1KDM4ERECQLMAOAMAOB
SCHEMBL12413592 0.70 CHEK1 (0.32) ALDH1A1KDM4EHSD17B10GAA
SCHEMBL7645026 0.69 ALDH1A1 (0.64) ALDH1A1MAPTKDM4EHSD17B10SMN1; SMN2
SCHEMBL17297883 0.68 SMN1; SMN2 (0.39) ALDH1A1MAPTKDM4ERECQLSMN1; SMN2
SCHEMBL8013436 0.67 CASP3 (0.49) ALDH1A1MAPTKDM4EMAOAMAOB
SCHEMBL166122 0.66 TDP1 (0.57) ALDH1A1MAPTGAAPOLBCASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8765757-B2 3-heterocyclic substituted indole derivatives and methods of use thereof MERCK SHARP & DOHME CORP. (US) 2014-07-01 US disclosed
US-20110165118-A1 3-HETEROCYCLIC SUBSTITUTED INDOLE DERIVATIVES AND METHODS OF USE THEREOF SCHERING CORPORATION 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110165118-A1 3-HETEROCYCLIC SUBSTITUTED INDOLE DERIVATIVES AND METHODS OF USE THEREOF IDO1, IDO2, HTR3C ALDH1A1 1668/4885MAPT 2307/4885KDM4E 1606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.